Phase 3 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have heart failure that has been confirmed through clinical assessment, heart ultrasound (echocardiogram), and hormone-level testing
- People who have a cardiac pacemaker fitted
- People who are physically able to complete a peak exercise test (an exercise test that measures the heart at maximum effort)
- People who are willing and able to give their formal consent to take part
Who may not be able to join:
- People who experience chest pain (angina) that limits how much exercise they can do
- People whose heart failure symptoms have been unstable, meaning their medications have been changed in the last three months
- People whose heart ultrasound images are of poor quality (confirm with trial site)
- People who are currently taking a type of medication called calcium channel blockers (CCBs)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: John Gierula, PhD, University of Leeds
Phone: 01133926642
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treadmill walk time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.